Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 1999, p. 2180-2188, Vol. 19, No. 3
Laboratorio Glaxo Wellcome-CSIC de
Biología Molecular y Celular, Centro de Biología
Molecular "Severo Ochoa" (Consejo Superior de Investigaciones
Científicas-Universidad Autónoma de Madrid), Universidad
Autónoma, 28049 Madrid, Spain,1 and
Department of Immunology, Mayo Clinic, Rochester, Minnesota
559052
Received 29 June 1998/Returned for modification 26 August
1998/Accepted 12 November 1998
The atypical protein kinase C (PKC) isotypes (
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Activation of I
B Kinase
by Protein Kinase
C Isoforms
/
PKC and
PKC) have been shown to be critically involved in important cell functions such as proliferation and survival. Previous studies have
demonstrated that the atypical PKCs are stimulated by tumor necrosis
factor alpha (TNF-
) and are required for the activation of NF-
B
by this cytokine through a mechanism that most probably involves the
phosphorylation of I
B. The inability of these PKC isotypes to
directly phosphorylate I
B led to the hypothesis that
PKC may use
a putative I
B kinase to functionally inactivate I
B. Recently
several groups have molecularly characterized and cloned two I
B
kinases (IKK
and IKK
) which phosphorylate the residues in the
I
B molecule that serve to target it for ubiquitination and
degradation. In this study we have addressed the possibility that
different PKCs may control NF-
B through the activation of the IKKs.
We report here that
PKC as well as the atypical PKCs bind to the
IKKs in vitro and in vivo. In addition, overexpression of
PKC
positively modulates IKK
activity but not that of IKK
, whereas
the transfection of a
PKC dominant negative mutant severely impairs
the activation of IKK
but not IKK
in TNF-
-stimulated cells. We
also show that cell stimulation with phorbol 12-myristate 13-acetate
activates IKK
, which is entirely dependent on the activity of
PKC
but not that of the atypical isoforms. In contrast, the inhibition of
PKC does not affect the activation of IKK
by TNF-
.
Interestingly, recombinant active
PKC and
PKC are able to
stimulate in vitro the activity of IKK
but not that of IKK
. In
addition, evidence is presented here that recombinant
PKC directly
phosphorylates IKK
in vitro, involving Ser177 and Ser181.
Collectively, these results demonstrate a critical role for the PKC
isoforms in the NF-
B pathway at the level of IKK
activation and
I
B degradation.
*
Corresponding author. Mailing address: Centro de
Biología Molecular "Severo Ochoa" (CSIC-UAM), Universidad
Autónoma, Canto Blanco, 28049 Madrid, Spain. Phone:
34-913978039. Fax: 34-929690055. E-mail:
jmoscat{at}cbm.uam.es.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|